VIE/IQVH (VIE/IQVH)

Vienna Stock Exchange: VIE/IQVH · EUR

€248

+3.60 (+1.5%)· Recorded snapshot

Market cap	41.3B
Revenue (ttm)	15.2B
Net income (ttm)	1.2B
EPS (ttm)	€7.40
P/E (trailing)	33.5x
P/E (forward)	19.9x

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 15.2B
Net income (ttm): 1.2B
EPS (ttm): €7.40
P/E (trailing): 33.5x
P/E (forward): 19.9x
Market cap: 41.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E19.9

P25 14.3P50 18.7P75 25.4

Trailing P/E33.5

P25 20.4P50 26.7P75 39.7

ROE21.4

P25 4.8P50 10.6P75 20.1

ROIC9.9

P25 5.8P50 9.5P75 18.2

Benchmarks · 1M

All VIE/IQVH indicators

Market & fundamental data

Available fields

231

Groups with data

Currency

USD

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	AT
Earnings date	2026-10-27
Employees	94,000
Employees change	4,000
Employees growth	4.44%
Enterprise value	EUR 53.8B
Exchange	Vienna Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Industry	Diagnostics & Research
Is primary listing	No
ISIN number	US46266C1053
Last earnings date	2026-10-27
Last refreshed	2026-10-29
Market cap	EUR 41.3B
Next earnings date	2027-02-05
Price	EUR 248.20
Price currency	EUR
Sector	Healthcare
SIC code	8731
Stock price date	2026-10-28
Symbol	vie/IQVH
Website	https://www.iqvia.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	76.79x
Average P/E ratio (3Y)	26.95x
Average P/E ratio (5Y)	31.22x
Earnings yield	2.98%
EV/Earnings	43.86x
EV/EBIT	23.96x
EV/EBITDA	17.75x
EV/FCF	29.41x
EV/Sales	3.47x
FCF / EV yield	3.4%
FCF yield	4.44%
Forward P/E	19.91x
Graham number	77.3138
Graham upside	-68.85%
Lynch fair value	EUR 93.73
Lynch upside	-62.24%
P/(FCF - SBC) ratio	26.38x
P/(OCF - SBC) ratio	19.26x
P/B ratio	6.9x
P/E ratio	33.52x
P/FCF ratio	22.54x
P/OCF ratio	17.12x
P/S ratio	2.71x
Price/EBITDA ratio	15.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	13.89%
EBITDA margin	18.01%
Effective tax rate	15.37%
FCF margin	11.79%
Gross margin	33.07%
Operating margin	13.89%
Pretax margin	9.55%
Profit margin	8.05%
Profit per employee	EUR 12,922
Profitable quarters	25
Profitable years	16
Revenue per employee	EUR 160,464
ROA	5.08%
ROA (5Y)	4.73%
ROCE	10.59%
ROE	21.39%
ROE (5Y)	20.22%
ROIC	9.89%
ROIC (5Y)	9.33%
SBC / revenue	1.75%
Tax / revenue	1.47%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	13.03%
EPS growth (Q)	8.81%
EPS growth (QoQ)	37.25%
EPS growth 10Y	9.76%
EPS growth 3Y	11.51%
EPS growth 5Y	16.01%
EPS growth quarters	1
EPS growth years	6
FCF growth	-5.97%
FCF growth (Q)	-13.6%
FCF growth (QoQ)	85.28%
FCF growth 3Y	16.32%
FCF growth 5Y	-2.57%
Gross profit growth	6.55%
Gross profit growth (Q)	9.1%
Gross profit growth 3Y	3.38%
Gross profit growth 5Y	4.95%
Net income growth	8.65%
Net income growth (Q)	5.74%
Net income growth (QoQ)	36.72%
Net income growth 3Y	7.7%
Net income growth 5Y	12.69%
Net income growth quarters	1
Net income growth years	0
OCF growth	-2.43%
OCF growth (Q)	-9.14%
OCF growth (QoQ)	47.85%
OCF growth 10Y	16.01%
OCF growth 3Y	11.72%
OCF growth 5Y	-1.83%
Operating income growth	6%
Operating income growth (Q)	6.11%
Operating income growth 3Y	6.9%
Operating income growth 5Y	13.74%
Revenue growth	8.85%
Revenue growth (Q)	8%
Revenue growth (QoQ)	1.37%
Revenue growth 10Y	14.32%
Revenue growth 3Y	5.23%
Revenue growth 5Y	5.04%
Revenue growth quarters	25
Revenue growth years	15

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -578.6M
Depreciation and amortization	EUR 640.4M
EBIT	EUR 2.1B
EBITDA	EUR 2.7B
EPS	EUR 7.40
Financing cash flow	EUR -29.9M
Free cash flow	EUR 1.8B
Free cash flow minus SBC	EUR 1.6B
Gross profit	EUR 5B
Income taxes	EUR 223.7M
Investing cash flow	EUR -2B
Net borrowing	EUR 1.1B
Net cash flow	EUR 383.1M
Net income	EUR 1.2B
Operating cash flow minus SBC	EUR 2.1B
Operating income	EUR 2.1B
Revenue	EUR 15.2B
Stock-based compensation	EUR 266.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.04
Book value per share	EUR 35.59
Debt / EBITDA	4.97
Debt / equity	2.4
Debt / FCF	7.85
Goodwill	EUR 15.2B
Interest coverage	3.06
Long-term assets	EUR 21B
Long-term liabilities	EUR 13.9B
Net cash (debt)	EUR -12.2B
Net cash / market cap	-29.65%
Net debt / EBITDA	4.46
Net debt / equity	2.05
Net debt / FCF	6.68
Piotroski F-Score	6
Property, plant and equipment	EUR 759.7M
Shareholders' equity	EUR 6B
Tangible book value	EUR -13.2B
Tangible book value per share	EUR -80.03
Total assets	EUR 26.8B
Total cash	EUR 2.1B
Total debt	EUR 14.4B
Total liabilities	EUR 20.9B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.58
Current assets	EUR 5.8B
Current liabilities	EUR 7B
Current ratio	0.83
Net working capital	EUR -2.2B
Quick ratio	0.74
Working capital	EUR -1.2B
Working capital turnover	-7.91

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	3.88%
Shareholder yield	3.88%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 187.18
1D price change	1.47%
1M price change	4.02%
1M total return	4.02%
1W price change	3.89%
1W total return	3.89%
1Y price change	32.66%
1Y return CAGR	32.68%
1Y total return	32.66%
20-day SMA	EUR 237.85
200-day SMA	EUR 180.39
3M price change	33.37%
3M total return	33.37%
3Y price change	43.8%
3Y return CAGR	12.87%
3Y total return	43.8%
50-day SMA	EUR 232.52
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 253.50
52-week high date	2026-10-27
52-week low	EUR 130.20
52-week low date	2026-05-05
5Y price change	11.8%
5Y return CAGR	2.26%
5Y total return	11.8%
6M price change	77.86%
6M total return	77.86%
All-time high	EUR 253.50
All-time high date	2026-10-27
All-time low	EUR 78.50
All-time low date	2020-03-23
Average true range (ATR)	EUR 4.47
Average volume	4.2
Change from 52-week high	-2.09%
Change from 52-week low	90.63%
Change from all-time high	-2.09%
Change from all-time low	216.18%
Change from open	1.55%
Day's gap	-0.08%
High price	EUR 248.20
Low price	EUR 244.10
Monthly RSI	64.81
Open price	EUR 244.40
Position in 52-week range	100%
Previous close	EUR 244.60
Price vs 150-day SMA	32.6%
Price vs 20-day SMA	4.35%
Price vs 200-day SMA	37.59%
Price vs 50-day SMA	6.74%
Relative volume	3.86
RSI	64.37
Sharpe ratio	0.82
Sharpe ratio (3Y)	0.43
Sharpe ratio (5Y)	0.11
Sortino ratio	1.34
Sortino ratio (3Y)	0.81
Sortino ratio (5Y)	0.33
Weekly RSI	73.99
YTD price change	28.3%
YTD total return	28.3%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	156.5M
Shares change (QoQ)	-0.18%
Shares change (YoY)	-3.88%
Shares held by insiders	0.97%
Shares held by institutions	98.29%
Short ratio	2.1 days

Deeper analysis on VIE/IQVH

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/IQVH report

Is a complete VIE/IQVH research report available?

No complete published report is available for vie/IQVH (VIE/IQVH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/IQVH (VIE/IQVH)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/IQVH

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All VIE/IQVH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/IQVH

Frequently asked questions